site map  

Protein C

  PRODUCTS ORDERING SERVICES ABOUT US FAQ/TECH NOTES CONTACT

Human Proteins   Bovine Proteins   Mouse Proteins   Other Species  Inhibitors

   Substrates   Antibodies   Sample Collection Tubes  Assay Kits  Deficient Plasmas  Pricing

 

 

 


Haematologic Technologies, Inc.

57 River Road

Essex Junction, VT USA

Tel: 802.878.1777

Fax: 802.878.1776

Email: hti@haemtech.com

HOME PAGE

DOMAIN STRUCTURE OF PROTEIN C The domain structure of protein C is represented, where: GLA = region containing γ-carboxyglutamic acid residues, EGF = region containing sequences homologous to human epidermal growth factor, AP = activation peptide released upon conversion of the zymogen to the active serine protease, CATALYTIC DOMAIN = region containing the serine protease catalytic triad. The arrow indicates the site which is proteolytically cleaved by thrombin during activation of the zymogen.

The vitamin K-dependent zymogen, protein C, is synthesized in the liver as a single chain polypeptide and is subsequently converted to a disulfide linked heterodimer, by removal of a dipeptide (Lys-146 and Arg-147) from the precursor molecule (1,2). Trace quantities of the single chain form have been observed in plasma. The light chain, which is responsible for the calcium dependent binding of protein C to phospholipid vesicles, contains 11 γ-carboxyglutamic acid (gla) residues, 1 b-hydroxyaspartic acid residue, and 2 epidermal growth factor (EGF) homology domains. The serine protease catalytic triad is located in the heavy chain. Human protein C is susceptible to proteolytic cleavage of a peptide (Mr=3000) from the COOH-terminal end of the heavy chain, yielding an altered form referred to as β-protein C. No functional distinction between α- and β-protein C has been observed. A single cleavage at Arg-12 (Arg-14 in bovine) of the heavy chain of human protein C converts the zymogen into the serine protease, activated protein C. This cleavage is catalyzed by a complex between α-thrombin and the endothelial cell surface protein thrombomodulin. In contrast to the other vitamin K dependent coagulation factors, activated protein C functions as an anticoagulant by catalyzing the proteolytic inactivation of factors Va and VIIIa. APC also contributes to the fibrinolytic response by complex formation with plasminogen activator inhibitors. 


Bovine protein C is prepared from fresh citrated bovine plasma by a modification of the Walker procedure (3), as described by Haley et al. (4). Human protein C is prepared from fresh frozen citrated human plasma using a combination of immunoaffinity chromatography (5), and conventional techniques (4,9). Protein C is provided in 50% (vol/vol) glycerol/H2O and should be stored at -20oC. Purity is determined by SDS-PAGE analysis and activity is measured using a chromogenic substrate based assay.  

Properties of Protein C

Localization: Plasma
Plasma concentration: 4-5 µg/ml (human) (6)
5-10 µg/ml (bovine) (2)
Mode of action: Zymogen; precursor to the serine protease activated protein C (APC)
Molecular weight: 62,000 (human) (7)
58,000 (bovine) (7)
Extinction coefficient:
E
1 %
1 c m, 280 nm
= 14.5 (human) (7)
= 13.7 (bovine) (7)
Isoelectric point: 4.4-4.8 (human) (8)
4.2-4.5 (bovine) (8)
Structure: two chains, Mr=41,000 and 21,000, disulfide linked, NH2-terminal gla domain two EGF domains
Percent carbohydrate: 23 % (human) (7)
14 % (bovine) (7)
Post-translational modifications: eleven gla residues (bovine), nine gla residues (human), one β-hydroxyaspartate

Catalog Number

Description

HCPC-0070

Human Protein C

BCPC-1070

Bovine Protein C

MCPC-5070

Mouse Protein C (indefinitely backordered)

PRICING

INQUIRE ABOUT THIS PRODUCT

References 

1. Esmon, C.T., Progress in Thromb. and Hemosts., 10, 25 (1984). 
2. Stenflo, J., Semin. in Thromb. and Hemostas., 10, 109 (1984). 
3. Walker, F.J., et al., Biochim. Biophys. Acta, 571, 333 (1979). 
4. Haley, P.E., et al., J. Biol. Chem., 264, 16303 (1989). 
5. Jenny, R.J., et al., Prep. Biochem., 16, 227 (1986). 
6. Griffen, J.H., et al., Blood, 60, 261 (1982). 
7. Kisiel, W., et al., Methods Enzymol., 80, 320 (1981). 
8. Discipio, R.G., et al., Biochemistry, 18, 899 (1979). 
9. Bajaj, S.P., et al., Prep. Biochem., 11, 397 (1981). 

 Please inquire about products not listed.  We can also custom purify proteins from other species. 

© 2004 Haematologic Technologies, Inc. All Rights Reserved